Pathogenic Alzheimer's disease cascade is activated by faulty norepinephrine signaling
In preclinical experiments, University of Alabama at Birmingham researchers have revealed a key missing piece of the Alzheimer's disease puzzle. That allowed proof-of-concept experiments—using an existing drug—that dramatically ...
Jan 15, 2020
6
662